Bianca J. Lee

1.1k total citations
9 papers, 99 citations indexed

About

Bianca J. Lee is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Bianca J. Lee has authored 9 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Hematology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Bianca J. Lee's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer Mechanisms and Therapy (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Bianca J. Lee is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer Mechanisms and Therapy (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). Bianca J. Lee collaborates with scholars based in United States and Romania. Bianca J. Lee's co-authors include Trever G. Bivona, Gorjan Hrustanovic, Mallika Singh, Nuntana Dinglasan, David Wildes, Jacqueline A.M. Smith, Elena S. Koltun, Kyle J. Seamon, Adrian L. Gill and Jim Cregg and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Bianca J. Lee

7 papers receiving 98 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bianca J. Lee United States 4 60 53 33 17 10 9 99
J.J. Soto Castillo Spain 4 50 0.8× 38 0.7× 27 0.8× 9 0.5× 11 1.1× 14 103
Michel Velez United States 6 71 1.2× 54 1.0× 50 1.5× 24 1.4× 8 0.8× 16 110
Max M. Quinn China 3 77 1.3× 82 1.5× 59 1.8× 20 1.2× 16 1.6× 3 140
P. Damiano Italy 4 36 0.6× 52 1.0× 58 1.8× 20 1.2× 9 0.9× 5 94
Alejandro Falcón Spain 6 54 0.9× 89 1.7× 44 1.3× 24 1.4× 9 0.9× 29 135
Yasutaka Matsunaga Japan 5 78 1.3× 44 0.8× 25 0.8× 28 1.6× 19 1.9× 10 131
Andrew Calinisan United States 4 86 1.4× 89 1.7× 37 1.1× 15 0.9× 11 1.1× 12 140
Lauren Hargis United States 4 83 1.4× 88 1.7× 37 1.1× 14 0.8× 11 1.1× 7 136
Leonardo Forero United States 4 47 0.8× 66 1.2× 39 1.2× 10 0.6× 9 0.9× 7 113

Countries citing papers authored by Bianca J. Lee

Since Specialization
Citations

This map shows the geographic impact of Bianca J. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bianca J. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bianca J. Lee more than expected).

Fields of papers citing papers by Bianca J. Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bianca J. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bianca J. Lee. The network helps show where Bianca J. Lee may publish in the future.

Co-authorship network of co-authors of Bianca J. Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Bianca J. Lee. A scholar is included among the top collaborators of Bianca J. Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bianca J. Lee. Bianca J. Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mahauad‐Fernandez, Wadie D., Yu Chi Yang, Ian Lai, et al.. (2025). Targeting the MYC oncogene with a selective bi-steric mTORC1 inhibitor elicits tumor regression in MYC-driven cancers. Cell chemical biology. 32(8). 994–1012.e11.
2.
3.
Mahauad‐Fernandez, Wadie D., Yu Chi Yang, Ian Lai, et al.. (2023). Abstract LB015: Bi-steric mTORC1-selective inhibitors activate 4EBP1, suppress MYC, restore anti-tumor immunity, and cooperate with immune checkpoint inhibition to elicit tumor regression. Cancer Research. 83(8_Supplement). LB015–LB015. 1 indexed citations
4.
Popescu, Bogdan, Carlos Stahlhut, Bianca J. Lee, et al.. (2023). Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML. Cell Reports Medicine. 4(11). 101290–101290. 6 indexed citations
5.
Gustafson, W. Clay, David Wildes, Meghan A. Rice, et al.. (2022). Direct targeting of RAS in pancreatic ductal adenocarcinoma with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor.. Journal of Clinical Oncology. 40(4_suppl). 591–591. 23 indexed citations
6.
Lee, Bianca J., Sharmila Mallya, Nuntana Dinglasan, et al.. (2021). Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia. Frontiers in Oncology. 11. 673213–673213. 11 indexed citations
7.
Lee, Bianca J., Nuntana Dinglasan, G. Leslie Burnett, et al.. (2019). Abstract B108: 4EBP3 mRNA as a biomarker of therapeutic response to treatment with mTORC1 inhibitors. Molecular Cancer Therapeutics. 18(12_Supplement). B108–B108.
8.
9.
Hrustanovic, Gorjan, Bianca J. Lee, & Trever G. Bivona. (2013). Mechanisms of resistance to EGFR targeted therapies. Cancer Biology & Therapy. 14(4). 304–314. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J.J. Soto Castillo Breakdown of academic impact, for papers by Michel Velez Breakdown of academic impact, for papers by Max M. Quinn Breakdown of academic impact, for papers by P. Damiano Breakdown of academic impact, for papers by Alejandro Falcón Breakdown of academic impact, for papers by Yasutaka Matsunaga Breakdown of academic impact, for papers by Andrew Calinisan Breakdown of academic impact, for papers by Lauren Hargis Breakdown of academic impact, for papers by Leonardo Forero
Rankless by CCL
2026